In the generative AI surge, global pharma explores AI for innovation. Join Sharon Chen and Bogong Zhu at CMAC to discuss AI's impact on clinical research.
AlphaPrime integrates its AuroraPrime platform with OpenAI, enhancing clinical research with ChatGPT and exploring AGI applications in drug development.
On October 12, 2022, AlphaPrime Life Sciences completed A+ round financing of tens of millions, led by Han Kang Capital and advised by Huaxing Capital.